Therefore, according to several large public databases, we conducted in-depth bioinformatics research on the CALR expression in Pan-cancer to assess the possibility of CALR as a potential therapeutic target and survival biomarker, which provided additional information for exploring the mechanism of tumor progression, predicting the prognosis and researching new targeted drugs. The gene discussed is CALR; the disease is polyarteritis nodosa.